Trenbolone

Trenbolone is a anabolic steroid used by veterinarians on livestock to increase muscle growth and appetite. To increase its effective half-life, trenbolone is not used in an unrefined form, but is rather administered as ester derivatives such as trenbolone acetate, trenbolone enanthate, or trenbolone cyclohexylmethylcarbonate. Trenbolone and its derivatives are considered Schedule III drugs under the Controlled Substances Act.
History[edit]
Trenbolone was first synthesized in 1963 by Hoechst-Roussel. The company started to produce the trenbolone acetate under the names Finajet and Finaject in the France. In the late 1980s, the company discontinued the production of this drug.
Pharmacology[edit]
Trenbolone exhibits interesting pharmacodynamics. It has both androgenic and anabolic effects. Once metabolized, the drug has the effect of increasing ammonium ion uptake by muscle, leading to an increase in the rate of protein synthesis. It also has the secondary effects of stimulating appetite and decreasing the rate of catabolism, as all anabolic steroids are believed to; however, catabolism likely increases significantly once the steroid is no longer taken.
Side Effects[edit]
Trenbolone has several potential side effects, many of which are typical for all anabolic steroids. These include oily skin, aggressive behavior, acne, and hair loss. Trenbolone is also notorious for causing a temporary increase in thyroid hormone levels, which can then cause an increase in prolactin levels.
Legal Status[edit]
In the United States, trenbolone is classified as a Schedule III drug under the Controlled Substances Act. It is also a controlled substance in Canada under Schedule IV. In the United Kingdom, trenbolone is classified as a Class C drug.
See Also[edit]
This article is a Anabolic steroid-related stub. You can help WikiMD by expanding it!
```
This template is designed for marking articles related to anabolic steroids as stubs, indicating that they are short or incomplete articles on the subject of anabolic steroids. By using this template, contributors are encouraged to expand the article to include more comprehensive information on the topic.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
